MYCOPHENOLATE
Clinical Indication
Immunosuppression following renal transplantation
Comments
Exception agreed to red status: Full shared care to allow GPs to continue supplying to historical patients still on shared care where appropriate for patient and the GP agrees.
Local guidance
Reviewed by LMSG Feb 2018
Date of classification
February 2018
Orange
Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.